Syra Health Corp.
SYRA
$0.17
$0.0431.54%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.73% | -13.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.73% | -13.27% | |||
| Cost of Revenue | 0.84% | -5.02% | |||
| Gross Profit | 6.62% | -26.35% | |||
| SG&A Expenses | -7.19% | 0.01% | |||
| Depreciation & Amortization | -57.41% | -10.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.62% | -4.44% | |||
| Operating Income | 41.56% | -267.41% | |||
| Income Before Tax | 40.42% | -255.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.42% | -255.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.42% | -255.19% | |||
| EBIT | 41.56% | -267.41% | |||
| EBITDA | 42.55% | -296.50% | |||
| EPS Basic | 40.21% | -256.60% | |||
| Normalized Basic EPS | 40.68% | -257.58% | |||
| EPS Diluted | 40.21% | -256.60% | |||
| Normalized Diluted EPS | 40.68% | -257.58% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||